Tempest Therapeutics board member Stella Xu resigns effective Jan 5, 2022

Tempest Therapeutics, Inc.

Stella Xu notified the Board of her resignation on Dec 20, 2021, effective Jan 5, 2022.
Resignation was not due to any disagreement with the company on operations, policies, or practices.
No replacement has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stella Xu

Director

TPST · Tempest Therapeutics, Inc.

Effective: 2022-01-05
Filed: December 23, 2021, 6:59 PM ET

On December 20, 2021, Stella Xu notified the board of directors (the “Board”) of Tempest Therapeutics, Inc. (the “Company”) of her decision to resign as a member of the Board, effective January 5, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Stella Xu resigned as Director at Tempest Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On December 20, 2021, Stella Xu notified the board of directors (the “Board”) of Tempest Therapeutics, Inc. (the “Company”) of her decision to resign as a member of the Board, effective January 5, 2022.

View on SEC.gov

Tempest Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-21-025555

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.